Istodax 10 MG kits
Ended Awarded
- Contract number
- SPE2DR26F0VQ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,480
Award facts
- Contract value 100% obligated
- $11,479.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,479.79 to AmerisourceBergen Drug Corp for ISTODAX 10 mg kits, with an ultimate completion date of October 24, 2025. This is a firm fixed price, non-set-aside contract executed on October 23, 2025, with performance to be fulfilled at the awardee's corporate office location in Conshohocken, Pennsylvania. ISTODAX (romidepsin) is a histone deacetylase inhibitor used in oncology for treating cutaneous T-cell lymphomas and peripheral T-cell lymphomas, representing a specialized pharmaceutical product within the federal medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime contract vehicle designated SPE2DX and extending through December 2026. As a major pharmaceutical distributor serving the Defense Health Agency and other federal healthcare systems, AmerisourceBergen Drug Corp maintains a broad portfolio of brand-name and generic medications, specialty drugs, and medical supplies supporting military healthcare operations globally. The competitive nature of this award, combined with the company's extensive federal contracting history with DLA, demonstrates its established capability to meet specialized pharmaceutical procurement requirements within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F0VQ3?
SPE2DR26F0VQ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DR26F0VQ3 worth?
The government has obligated $11,480 on SPE2DR26F0VQ3.
Is contract SPE2DR26F0VQ3 an order under another contract?
Yes. SPE2DR26F0VQ3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0VQ3 competed?
The extent of competition for SPE2DR26F0VQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award